ReviewFrontiers in physiology2026
Skeletal muscle overuse injury: pathophysiological mechanisms, molecular pathways, and rehabilitation strategies.
Review in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skeletal muscle overuse injury (OUI) is a load-related condition that develops when repeated mechanical loading exceeds the adaptive and reparative capacity of skeletal muscle. Unlike acute traumatic injury or delayed-onset muscle soreness after unaccustomed eccentric exercise, chronic skeletal muscle OUI is characterized by recurrent subthreshold loading, insufficient recovery, persistent low-grade inflammation, impaired regeneration, and maladaptive remodeling. This narrative review summarizes and critically appraises current evidence on the conceptual boundaries, pathophysiological mechanisms, molecular pathways, and rehabilitation strategies of skeletal muscle OUI. Particular emphasis is placed on distinguishing direct skeletal muscle evidence from indirect or extrapolative evidence derived from acute injury models, adjacent musculoskeletal disorders, disease models, or preclinical studies. Key mechanisms include myofiber microdamage, satellite-cell-mediated repair, extracellular matrix remodeling, inflammatory signaling, oxidative stress, mitochondrial dysfunction, protein turnover, and myogenic transcriptional regulation. Current management remains centered on individualized load modification, graded rehabilitation, correction of biomechanical contributors, and criteria-based return to activity. Pharmacological and physical modalities may provide adjunctive symptom control in selected cases, whereas regenerative, gene-based, wearable-sensor-based, and artificial-intelligence-assisted approaches remain emerging or experimental for chronic skeletal muscle OUI. By integrating mechanistic evidence with rehabilitation practice and evidence appraisal, this review provides a focused framework for understanding, preventing, and managing skeletal muscle OUI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.